This is the authors' abstract. We don't add key points for this paper.
We thank Dr Wright, and co-authors,1 for supporting our conservative interpretation of the meta-analysis data on pre-eclampsia prevention with calcium in our Cochrane Review,2 in which we stated: ‘These data should be interpreted with caution because of the possibility of small-study effects or publication bias. In the largest trial, the reduction in pre-eclampsia was modest (8%) and the CI included the possibility of no effect’. Our subgroup analysis by study sample size (analysis 3.2) found greater pooled effectiveness with smaller studies compared with larger studies. The authors’ questioning of the World Health Organization (WHO) recommendations supporting calcium supplementation in low-intake populations fails to recognise that the WHO recommendation was based on a broader consideration of evidence, including the key finding of our review, that ‘The composite outcome maternal death or serious morbidity was reduced with calcium supplementation (four trials, 9732 women; RR 0.80, 95% CI 0.66–0.98)’. There was one maternal death with calcium supplementation versus six maternal deaths with placebo. These important outcomes were not subject to heterogeneity or small trial effects. Pre-eclampsia becomes evident in late pregnancy, but its origins are in early pregnancy. The data that we reviewed related to late pregnancy supplementation, which may partially miss the boat with respect to pre-eclampsia prevention. Low-dose calcium supplementation before pregnancy, and continued up to 20 weeks of gestation, may reduce the continuum of pregnancy loss/pre-eclampsia (RR 0.82, 95% CI 0.66–1.00) in a trial with suboptimal compliance. In a compliant subgroup, pre-eclampsia was reduced by 34% (RR 0.66, 95% CI 0.44–0.98).3 A more recent meta-analysis concluded that ‘Low- and high-dose calcium supplementation are effective for pre-eclampsia prevention in women with low calcium intake’,4 and two simultaneous trials have reported calcium supplementation with 500 mg daily to be non-inferior to larger doses.5 This evidence opens the way for staple food fortification (which can deliver 500 mg calcium daily) as a method of improving pregnancy outcomes while correcting calcium dietary deficiency at a population level. The median daily calcium intake in pregnant individuals attending public health services in countries such as South Africa and Zimbabwe is considerably less than half the recommended daily intake.3 It would be unfortunate if the restricted focus of the article by Wright et al. were to undermine the efforts of the WHO, and discourage health authorities in such countries from investing in strategies to correct extreme dietary deficiencies in this essential nutrient. Although we agree that the metanalytic bathwater of late pregnancy calcium effects on pre-eclampsia is muddied, let's not throw out the baby. GJH wrote the first draft of the letter. All authors contributed to writing the letter and approved the final version for publication. Co-authors of articles cited.2, 3 None. None. None required. No new data were generated.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hofmeyr et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: